- Trials with a EudraCT protocol (207)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
207 result(s) found for: Open field.
Displaying page 1 of 11.
EudraCT Number: 2009-015916-16 | Sponsor Protocol Number: 2.707/03/2010 | Start Date*: 2009-11-06 |
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust | ||
Full Title: A Comparison of Postural and Ibopamine Challenges between Progressive and Non-Progressive Glaucoma Patients | ||
Medical condition: Glaucoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-002531-15 | Sponsor Protocol Number: 09/0959 | Start Date*: 2016-11-14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:UCL Comprehensive Clinical Trials Unit | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A phase II, open label, non-randomised, single centre, clinical trial of ANX776 in Healthy Volunteers and patients with Glaucoma, Age-Related Macular Degeneration, and Optic Neuritis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Glaucoma, Age-related Macular Degeneration, and Optic Neuritis. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-005159-34 | Sponsor Protocol Number: IG1103 | Start Date*: 2014-06-16 |
Sponsor Name:Instituto Grifols, S.A. | ||
Full Title: A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Soft Tissue Open Surgeries | ||
Medical condition: Treatment of haemorrhage resulting from soft tissue surgical procedure | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-005128-40 | Sponsor Protocol Number: IG1102 | Start Date*: 2014-06-16 |
Sponsor Name:Instituto Grifols, S.A. | ||
Full Title: A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Parenchymous Tissue Open Surge... | ||
Medical condition: Treatment of haemorrhage resulting from parenchymous tissue surgical procedure | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-011157-41 | Sponsor Protocol Number: LT2345-PIII-12/08 | Start Date*: 2009-07-24 | ||||||||||||||||
Sponsor Name:laboratoires théa | ||||||||||||||||||
Full Title: Efficacy and Safety assessment of T2345 unpreserved eyedrops versus Xalatan® in ocular hypertensive or glaucomatous patients. Phase III study, multicentre, international, randomised, investigator-m... | ||||||||||||||||||
Medical condition: The study population is suffering from glaucoma. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) BE (Completed) ES (Completed) PT (Completed) IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002102-37 | Sponsor Protocol Number: ORL-CENS-2015 | Start Date*: 2015-10-02 | ||||||||||||||||
Sponsor Name:Fundació Parc Taulí | ||||||||||||||||||
Full Title: Open randomized clinical trial to compare the efficacy of hypotensive anesthesia with clonidine or dexmedetomidine during endoscopic nasal surgery | ||||||||||||||||||
Medical condition: Nasosinusal endoscopic surgery in patients with chronic sinusitis and/or nasal polyposis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001634-17 | Sponsor Protocol Number: MAF/ISS/OPH/GLA/035 | Start Date*: 2013-10-30 |
Sponsor Name:AZIENDA OSPEDALIERA S. PAOLO | ||
Full Title: LONG-TERM 24-HOUR INTRAOCULAR PRESSURE CONTROL AND PROGRESSION RATE OBTAINED WITH THE ASSOCIATION OF COMBIGAN IN THE MORNING AND GANFORT IN THE EVENING COMPARED WITH LATANOPROST IN HIGH RISK OPEN-A... | ||
Medical condition: Patients with glaucoma open angle or glaucoma exfoliative with high risknewly diagnosed and untreated. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-005127-16 | Sponsor Protocol Number: IG1101 | Start Date*: 2014-06-16 |
Sponsor Name:Instituto Grifols, S.A. | ||
Full Title: A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis during Peripheral Vascular Surgery | ||
Medical condition: Treatment of haemorrhage resulting from a vascular surgical procedure | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-003140-27 | Sponsor Protocol Number: V1.0/OPHT-020606 | Start Date*: 2006-07-25 |
Sponsor Name:Department of Clinical Pharmacology | ||
Full Title: Effects of non-specific Endothelin-A receptor blockade on ocular blood flow in patients with glaucoma | ||
Medical condition: patients with primary open angle glaucoma in comparision to a healthy control group. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-000653-22 | Sponsor Protocol Number: GART1013 | Start Date*: 2006-07-26 | |||||||||||
Sponsor Name:Moorfields Eye Hospital | |||||||||||||
Full Title: The UK Glaucoma Treatment Study | |||||||||||||
Medical condition: Primary open-angle Glaucoma Pseudoexfoliation Glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001680-30 | Sponsor Protocol Number: 529 | Start Date*: 2007-11-02 |
Sponsor Name:Bausch&Lomb Dr Gerhard Mann chem.-Fabrik GmbH | ||
Full Title: Randomized parallel-group, multicentre study to evaluate the after-use sensation and safety of carteolol LA 2% versus timolol LA 0.5% in simple intra-ocular hypertension and glaucoma. | ||
Medical condition: Adult patients suffering from unilateral or bilateral ocular hypertension or POAG, IOP controlled with beta-blocker monotherapy (IOP < 21 mmHg and visual field stable) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) PT (Completed) BE (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-012799-28 | Sponsor Protocol Number: MAF-AGN-OPH-GLA-010 | Start Date*: 2009-11-11 |
Sponsor Name:Allergan | ||
Full Title: Estudio Piloto de tres meses, multicéntrico, enmascarado para el Investigador, para evaluar la eficacia y la seguridad de una combinación fija de Bimatoprost/Timolol versus Latanoprost en pacientes... | ||
Medical condition: Treatment-Naïve Patients with Open Angle Glaucoma at High Risk of Glaucomatous Progression. Pacientes Naïve con glaucoma de ángulo abierto con alto riesgo de progresión glaucomatosa. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) PT (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-000913-35 | Sponsor Protocol Number: BECRO/OV/DORZO | Start Date*: 2019-05-21 | |||||||||||||||||||||
Sponsor Name:BECRO (Cyprus) Ltd | |||||||||||||||||||||||
Full Title: A Randomized, Observer-blind, two Parallel Group, Multi-center, Clinical Trial for Comparing the Efficacy and Tolerability of Dorzo-Vision® sine Preservative-Free Eye Drops vs. Trusopt® Preservativ... | |||||||||||||||||||||||
Medical condition: Open angle glaucoma or ocular hypertension | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GR (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005091-42 | Sponsor Protocol Number: 192024-041D | Start Date*: 2012-05-08 | |||||||||||||||||||||
Sponsor Name:Allergan Limited | |||||||||||||||||||||||
Full Title: An Open Label (Stage 1) and Randomized (Stage 2), 24-Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension | |||||||||||||||||||||||
Medical condition: open-angle glaucoma (OAG) and ocular hypertension (OHT) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-004111-32 | Sponsor Protocol Number: OTRAPAC | Start Date*: 2013-03-01 | |||||||||||
Sponsor Name:Charité Universitätsmedizin Berlin | |||||||||||||
Full Title: Prospective, open-label, multicentre study on the incidence of Squamous Cell Carcinoma and Actinic Keratoses in solid organ transplant recipients treated with per protocol, cyclic field application... | |||||||||||||
Medical condition: Squamous Cell Carcinoma and Actinic Keratoses in solid organ transplant recipients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-006372-17 | Sponsor Protocol Number: Field-Cancerization | Start Date*: 2022-02-15 | |||||||||||
Sponsor Name:Muehlenkreiskliniken AoeR | |||||||||||||
Full Title: Evaluation of clinical and immunological effects of PD-1 inhibition on actinic keratoses in patients with advanced or metastatic cutaneous squamous cell carcinoma in combination with a pronounced f... | |||||||||||||
Medical condition: advanced or metastatic cutaneous squamous cell carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004262-95 | Sponsor Protocol Number: 0130A01SA | Start Date*: 2019-01-07 | ||||||||||||||||
Sponsor Name:Santen SAS | ||||||||||||||||||
Full Title: Phase III, Multinational, Multicenter, Investigator-Masked, Randomised, Active-Controlled Trial, comparing the efficacy and safety of DE-130A with Xalatan® in Patients with Open-Angle Glaucoma or O... | ||||||||||||||||||
Medical condition: Open-Angle Glaucoma or Ocular Hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) GB (GB - no longer in EU/EEA) DE (Completed) EE (Completed) PL (Completed) ES (Completed) BE (Completed) AT (Completed) LV (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-005228-10 | Sponsor Protocol Number: TG-MV-008 | Start Date*: 2008-10-03 | |||||||||||
Sponsor Name:ThromboGenics NV | |||||||||||||
Full Title: An Open Label, Single Center Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion | |||||||||||||
Medical condition: Focal vitreomacular adhesion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001855-10 | Sponsor Protocol Number: SNAP1 | Start Date*: 2019-01-22 | |||||||||||
Sponsor Name:Department of Ophtalmology, Rigshospitalet-Glostrup | |||||||||||||
Full Title: Steroids and Non-steroidal Anti-inflammatory drugs in the Postoperative regime after trabeculectomy. An investigator-initiated randomized study (The SNAP study) | |||||||||||||
Medical condition: Medically uncontrolled glaucoma that requires filtration surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005965-18 | Sponsor Protocol Number: ORL-CENS-2012 | Start Date*: 2012-02-21 | ||||||||||||||||||||||||||
Sponsor Name:Fundació Parc Taulí | ||||||||||||||||||||||||||||
Full Title: Open randomized trial to compare the bleeding during endoscopic nasal surgery after hypotensive anesthesia with clonidine or remifentanil. | ||||||||||||||||||||||||||||
Medical condition: Nasosinusal endoscopic surgery in patients with chronic sinusitis and/or nasal polyposis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
